Sabra Health Care REIT, Inc. (SBRA)

Real Estate · NMS

$19.72-0.30% today

Price as at 1 Oct 2026, 02:40 UTC. Quotes are delayed.

Fundamentals

Market cap$5.56B
P/E ratio35.0
Dividend yield5.46%
Revenue growth (YoY)+21.7%
Profit margin19.1%
Return on equity5.7%
52-week range$17.17 to $22.77

Valuation and ratings

Fair value estimate$11.05
Upside to fair value-44.0%
Analyst target (mean)$22.50
Analyst range$19.00 to $25.00
Analysts with price targets14
Consensus viewbuy
Moat score65/100
Overall rating38/100, low quality

Fair value: $11.05 (-44.0%), see how we got there

Sabra Health Care REIT, Inc. trades at $19.72, which is 44% above the $11.05 our fair value estimate puts on the business. On that measure it screens as expensive, which is not the same as saying it will fall.

Our moat model scores it 65 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.

It changes hands at 35.0 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.

SBRA dividend history

Dividend yield5.46%
Paid, trailing 12 months$1.20 per share
Most recent payment$0.300, ex 14 Aug 2026
5-year growth (p.a.)-2.3%
Consecutive years paid16

Dividends per share by year

YearTotal per sharePayments
2026 (year to date)$0.9003
2025$1.204
2024$1.204
2023$1.204
2022$1.204
2021$1.204
2020$1.354
2019$1.804
2018$1.804
2017$1.734
2016$1.674

Split-adjusted amounts in the listing currency, grouped by the calendar year of the ex-dividend date, from the filed record. Growth and streak figures compare complete years only.

SBRA earnings and analyst estimates

EPS estimate, next year$0.76
Expected EPS growth+14.3%
Expected revenue growth+9.8%

Recommendation mix, 16 published ratings

6 buy9 hold1 sell

Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.

About Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.

Industry: REIT - Healthcare FacilitiesEmployees: 58HQ: United States

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

SBRA passes 3 of our 30 screens today

Each screen prints the exact criteria it used, and the circumstances in which it is wrong.

Super investor ownership

10 of the funds we track reported a position in their latest SEC 13F filing. Largest first:

A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.

Politician trades in SBRA

We hold 7 disclosed trades in SBRA by members of Congress and executive-branch officials. The latest 5:

  • Daniel Goldman · HouseSell · $1,001 - $15,000 · traded 10 Apr 2023 · disclosed 19 May 2023
  • Daniel Goldman · HouseBuy · $1,001 - $15,000 · traded 1 Mar 2023 · disclosed 17 Apr 2023
  • Christopher L. Jacobs · HouseSell · $1,001 - $15,000 · traded 8 Nov 2022 · disclosed 12 Dec 2022
  • Christopher L. Jacobs · HouseBuy · $15,001 - $50,000 · traded 21 Jun 2022 · disclosed 28 Jul 2022
  • Greg Gianforte · HouseBuy · $50,001 - $100,000 · traded 21 Dec 2018 · disclosed 23 Jan 2019

A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.

SBRA peers

The largest companies in the same industry (REIT - Healthcare Facilities), then in the same sector.

Every real estate company we cover is on the Real Estate hub.

Common questions

Is Sabra Health Care REIT, Inc. (SBRA) undervalued?

Against our fair value estimate of $11.05, SBRA at $19.72 is 44% above fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.

Which funds own SBRA?

10 of the institutions we track reported a position in SBRA in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.

What is SBRA's P/E ratio?

SBRA trades at 35.0 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.

Does Sabra Health Care REIT, Inc. (SBRA) pay a dividend?

Yes. Sabra Health Care REIT, Inc. yields 5.46% at the current share price. It has paid $1.20 per share over the trailing twelve months. It has paid a dividend in each of the last 16 complete calendar years. A dividend is declared by the board and can be cut at any time; a yield is a fact about the current price, not a promise.

Where does SteadyShares get its SBRA data?

Fundamentals for SBRA come from company filings and exchange data, as listed on NMS; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 02:40 UTC and is delayed. Our data quality score for this company is 100/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for SBRA, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.